Steve Schonfeld’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.9K Buy
+132,888
New +$37.1K ﹤0.01% 2446
2025
Q3
Sell
-897,388
Closed -$1.1M 2339
2025
Q2
$1.1M Buy
897,388
+695,673
+345% +$759K 0.01% 1264
2025
Q1
$222K Buy
201,715
+47,015
+30% +$54.3K ﹤0.01% 1905
2024
Q4
$140K Sell
154,700
-81,900
-35% -$70.2K ﹤0.01% 1813
2024
Q3
$233K Sell
236,600
-919,636
-80% -$885K ﹤0.01% 1757
2024
Q2
$1.04M Buy
1,156,236
+975,678
+540% +$730K 0.01% 1191
2024
Q1
$213K Sell
180,558
-189,102
-51% -$208K ﹤0.01% 1758
2023
Q4
$337K Buy
369,660
+9,760
+3% +$7.21K ﹤0.01% 1397
2023
Q3
$300K Sell
359,900
-25,500
-7% -$29.4K ﹤0.01% 1326
2023
Q2
$462K Sell
385,400
-6,400
-2% -$7.97K ﹤0.01% 1250
2023
Q1
$494K Sell
391,800
-511,700
-57% -$979K ﹤0.01% 1174
2022
Q4
$1.96M Buy
903,500
+774,156
+599% +$6.37M 0.02% 828
2022
Q3
$1.55M Buy
129,344
+91,568
+242% +$1.14M 0.01% 1002
2022
Q2
$315K Sell
37,776
-57,824
-60% -$448K ﹤0.01% 1637
2022
Q1
$830K Sell
95,600
-26,900
-22% -$259K 0.01% 1085
2021
Q4
$1.39M Buy
122,500
+22,200
+22% +$264K 0.01% 805
2021
Q3
$1.26M Buy
+100,300
New +$923K 0.01% 872
2021
Q2
Sell
-49,902
Closed -$461K 2076
2021
Q1
$461K Buy
49,902
+6,060
+14% +$61.1K 0.01% 1177
2020
Q4
$423K Buy
+43,842
New +$432K 0.01% 1095

Other funds holding GOSS

Steve Schonfeld's GOSS Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Gossamer Bio (GOSS) in Q2 2026: 132,888 shares worth $21.9K. The stake represents ﹤0.01% of the portfolio and ranks #2446 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in GOSS as recently as Q2 2025.

Steve Schonfeld first reported a position in GOSS in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.96M in Q4 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Steve Schonfeld held 132,888 shares of Gossamer Bio worth $21.9K as of Q2 2026.
  • Gossamer Bio was a new Steve Schonfeld position in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2446 holding.
  • Steve Schonfeld first reported a position in Gossamer Bio in Q4 2020 and has held it in 19 quarters since.
  • Steve Schonfeld's Gossamer Bio position peaked at $1.96M in Q4 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.